Depression: all 8,245 studies

Page 24 of 83. Open to participants first (1,645), then studies with results posted, then the rest; newest registration first within each.

• Clinical Study of Generic and Brand Bupropion in DepressionCompletedNCT02209597Phase 4Results posted
• The Effect of Questionnaire Content on Measures of Pain Intensity, Magnitude of Disability, and Symptoms of Depression in Patients With Arm IllnessCompletedNCT02209259Not applicableResults posted
• Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast CancerCompletedNCT02203552Phase 2Results posted
• Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious DistressCompletedNCT02196506Phase 3Results posted
• Open Label Extension for GLYX13-C-202, NCT01684163TerminatedNCT02192099Phase 2Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive DisorderCompletedNCT02191397Phase 3Results posted
• Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.CompletedNCT02185131Phase 2Results posted
• Buprenorphine Used With Treatment Resistant Depression in Older AdultsCompletedNCT02181231Phase 1/2Results posted
• Predictors of Antidepressant ResponseCompletedNCT02178696Phase 4Results posted
• A Prospective, Open Label Study Evaluating JUVÉDERM® VOLBELLA With Lidocaine Treatment for the Correction of Skin Depressions in the Infra-orbital AreaCompletedNCT02176421Not applicableResults posted
• Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major DepressionCompletedNCT02176408Not applicableResults posted
• Incomplete Response in Late-Life Depression: Getting to Remission With BuprenorphineCompletedNCT02176291Phase 2Results posted
• IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM)CompletedNCT02176226Not applicableResults posted
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 StudyCompletedNCT02158546Phase 3Results posted
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 StudyCompletedNCT02158533Phase 3Results posted
• Study to Treat Major Depressive Disorder (MDD) With a New MedicationCompletedNCT02149836Phase 2Results posted
• A Helping Hand Among Low-Income PatientsCompletedNCT02147522Not applicableResults posted
• Preventing Depression in Late Life: A Model for Low and Middle Income CountriesCompletedNCT02145429Not applicableResults posted
• A Family-based Primary Care Intervention to Enhance Older Men's Depression CareCompletedNCT02143024Not applicableResults posted
• A Long-Term Safety Study of ALKS 5461CompletedNCT02141399Phase 3Results posted
• Nitrous Oxide as Treatment for Major Depression - a Pilot StudyCompletedNCT02139540Phase 2Results posted
• The ISLAND Study: InSuLa Assessed Needs for DepressionCompletedNCT02137369Phase 4Results posted
• Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive DisorderCompletedNCT02134808Phase 4Results posted
• A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for SuicideCompletedNCT02133001Phase 2Results posted
• The Antidepressive Effect of rTMS as add-on to ECTTerminatedNCT02123485Not applicableResults posted
• Depression and Anxiety in Rheumatoid ArthritisCompletedNCT02122406Results posted
• OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult FemalesCompletedNCT02116361Phase 2Results posted
• Enhanced Medical Rehabilitation in Older AdultsCompletedNCT02114879Not applicableResults posted
• Cognitive Behavioral Therapy (REBT/CBT) Evaluation for Dysthymia in the Practice of Clinical Social Work at Primary CareCompletedNCT02112708Not applicableResults posted
• Reducing the Burden of Depression Related DisabilityCompletedNCT02111811Not applicableResults posted
• Genomics Used to Improve DEpression DecisionsCompletedNCT02109939Not applicableResults posted
• Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department PatientsCompletedNCT02106325Phase 2Results posted
• Hypnosis in Pain Management, Anxiety and Depression in Oncological PatientsCompletedNCT02105740Not applicableResults posted
• Ketamine for Depression and Suicide RiskCompletedNCT02094898Phase 2Results posted
• Northern-Manhattan Hispanic Caregiver Intervention Effectiveness StudyCompletedNCT02092987Not applicableResults posted
• Internet-delivered Psychotherapy for DepressionTerminatedNCT02091856Not applicableResults posted
• Realizing Opportunities for Self EmpowermentCompletedNCT02087956Not applicableResults posted
• A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)CompletedNCT02085135Phase 3Results posted
• rTMS in Treatment Resistant DepressionCompletedNCT02080507Not applicableResults posted
• Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing BiasesCompletedNCT02079610Not applicableResults posted
• Pharmacokinetic Study of Bupropion Hydrochloride Products With Different Release PatternsCompletedNCT02078180Phase 4Results posted
• A Randomized Controlled Trial of PCIT-ED for Preschool DepressionCompletedNCT02076425Not applicableResults posted
• Endogenous Opioid Activity and Affective State in Insulin Resistant WomenCompletedNCT02069379Phase 4Results posted
• Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant TherapyCompletedNCT02058693Phase 4Results posted
• Omega 3 for Treatment of Depression in Patients With Heart FailureCompletedNCT02057406Phase 3Results posted
• Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBICompletedNCT02057081Not applicableResults posted
• Veteran Peer-Assisted Computerized Cognitive Behavioral Therapy for DepressionCompletedNCT02057042Not applicableResults posted
• Does Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression?TerminatedNCT02049385Phase 1/2Results posted
• Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive DisorderCompletedNCT02046564Phase 3Results posted
• Lurasidone Pediatric Bipolar StudyCompletedNCT02046369Phase 3Results posted
• Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological DisorderCompletedNCT02043197Results posted
• Imaging Dopamine Release in DepressionCompletedNCT02033369Phase 4Results posted
• INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) StudyCompletedNCT02022111Not applicableResults posted
• Omega-3 for Depression and Other Cardiac Risk Factors - 2CompletedNCT02021669Phase 2Results posted
• An Adaptive Treatment Strategy for Adolescent Depression-ContinuationCompletedNCT02017535Phase 1/2Results posted
• Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With VilazodoneCompletedNCT02015546Phase 3Results posted
• Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD)CompletedNCT02014363Phase 2Results posted
• Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work EnvironmentCompletedNCT02013609Phase 3Results posted
• Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety SymptomsCompletedNCT02013531Phase 3Results posted
• Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive TherapyCompletedNCT02012218Phase 3Results posted
• The Effect of a Father Inclusive Psychoeducation Program on Postnatal DepressionCompletedNCT02010840Not applicableResults posted
• A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant DepressionCompletedNCT01998958Phase 2Results posted
• Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost OutcomesCompletedNCT01993017Not applicableResults posted
• Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME)CompletedNCT01992393Not applicableResults posted
• A Phase III Study of SM-13496 in Patients With Bipolar I Depression.CompletedNCT01986101Phase 3Results posted
• Brain Mechanisms of Human MotivationCompletedNCT01976975Results posted
• Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older AdultsCompletedNCT01973283Phase 4Results posted
• A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive DisorderTerminatedNCT01957410Phase 2Results posted
• Prognosis of Depression in the Elderly (PRODE). A Multicentre, Longitudinal Study of Elderly Depressed Patients.CompletedNCT01952366Results posted
• Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety DisordersCompletedNCT01947647Not applicableResults posted
• Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive DisorderTerminatedNCT01944969Phase 3Results posted
• Low Field Magnetic Stimulation for Treatment Resistant DepressionCompletedNCT01944644Not applicableResults posted
• Ketamine for Suicidality in Bipolar DepressionCompletedNCT01944293Phase 1/2Results posted
• Investigation of Brain Network Dynamics in DepressionCompletedNCT01931995Not applicableResults posted
• Multiple Treatment Study Using Low Field Magnetic Stimulation for Bipolar DepressionCompletedNCT01929681Not applicableResults posted
• Predictors of Treatment Outcome With Cognitive Behavioral Therapy for DepressionCompletedNCT01922219Not applicableResults posted
• Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)CompletedNCT01920555Phase 2Results posted
• Effects of Treatment on Decision-making in Major DepressionCompletedNCT01916824Phase 4Results posted
• Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant DepressionTerminatedNCT01913535Phase 2Results posted
• Technology Assisted Programs That Promote Mental Health for TeenagersCompletedNCT01912729Not applicableResults posted
• Mobile Technology to Engage and Link Patients and Providers in Antidepressant TreatmentCompletedNCT01909973Not applicableResults posted
• Enhancing the Effectiveness of Electroconvulsive Therapy in Severe DepressionCompletedNCT01907217Phase 4Results posted
• Stepped Telemental Health Care Intervention for DepressionCompletedNCT01906476Not applicableResults posted
• Mindfulness Intervention to Study the Neurobiology of DepressionCompletedNCT01905267Not applicableResults posted
• Sunshine 2 Study for Women With DiabetesCompletedNCT01904032Phase 2Results posted
• Brain Aging and Treatment Response in Geriatric DepressionCompletedNCT01902004Phase 4Results posted
• Imaging Biomarkers for TMS Treatment of DepressionCompletedNCT01900314Not applicableResults posted
• Deep Brain Stimulation (DBS) for Treatment-Resistant Depression (TRD)CompletedNCT01898429Not applicableResults posted
• Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life DepressionCompletedNCT01896934Phase 4Results posted
• Enhancing Delivery of Problem Solving Therapy Using SmartPhone TechnologyCompletedNCT01891734Phase 1/2Results posted
• Vitamin D Supplementation for Bipolar DepressionCompletedNCT01884844Not applicableResults posted
• Nuedexta in Treatment-Resistant Major DepressionCompletedNCT01882829Phase 2Results posted
• Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in DepressionCompletedNCT01881763Phase 4Results posted
• PET and MRI Brain Imaging of Bipolar DisorderCompletedNCT01880957Not applicableResults posted
• Ketamine Plus Lithium in Treatment-Resistant DepressionCompletedNCT01880593Phase 2Results posted
• Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive DisorderCompletedNCT01878292Phase 3Results posted
• Low-Dose Naltrexone (LDN) for Depression Relapse and RecurrenceCompletedNCT01874951Phase 2Results posted
• A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety SymptomCompletedNCT01870843Phase 4Results posted
• Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older AdultsCompletedNCT01869374Phase 1/2Results posted
• Evaluation of Two Community-based Mental Health Interventions for Violence-Displaced Afro-Descendants in Colombia.CompletedNCT01856673Not applicableResults posted

← Depression overview